FTC sues major pharmacy advantage administrators above insulin costs The agency brought motion against Caremark, Express Scripts and Optum Rx, arguing their “anticompetitive and unfair” rebating practices “artificially inflated” the checklist price of everyday living-saving insulin medication. Sanders quickly condemned the go in an announcement Wednesday, noting he was disappointed https://daltonnmnig.mdkblog.com/36362512/about-healthcare-news